Table 1.
Demographic information on the group of SARS-CoV-2 positive patients, including information on pre-existing comorbidities.
| All SARS-CoV-2 patients (n = 3944) | Non-hospitalized (n = 2585) | Hospitalized patients (n = 1359) | Hospitalized patients without ICU admission (n = 1178) | Hospitalized patients with ICU admission (n = 181) | Survivors (n = 3620) | Non-survivors (n = 324) | |
|---|---|---|---|---|---|---|---|
| Body Mass Index | 25.9 (22.7–29.8) | 25.8 (22.6–29.7) | 26.0 (22.7–29.9) | 25.7 (22.6–29.4) | 27.3 (23.5–31.4) | 26.0 (22.7–29.9) | 25.2 (22.0–28.8) |
| Age | 53.0 (36.0–69.0) | 44.0 (31.0–58.0) | 70.0 (55.0–80.0)** | 71.0 (54.0–81.0) | 69.0 (58.0–75.0) | 50.0 (34.0–64.0) | 81.0 (73.0–87.0)** |
| Male Sex | 41.9 | 35.6 | 53.9** | 51.4 | 70.2** | 40.6 | 56.2** |
| Diabetes | 13.4 | 8.0 | 23.5** | 23.4 | 24.3 | 12.0 | 28.7** |
| Ischemic heart disease | 9.1 | 5.2 | 16.5** | 16.0 | 19.3 | 8.0 | 21.0** |
| Heart failure | 4.2 | 1.5 | 9.4** | 9.5 | 8.8 | 3.1 | 16.7** |
| Arrhythmia | 10.4 | 4.9 | 20.9** | 21.0 | 20.4 | 8.5 | 32.1** |
| Stroke | 6.7 | 3.1 | 13.5** | 14.1 | 9.9 | 5.7 | 17.9** |
| COPD or asthma | 11.4 | 9.2 | 15.7** | 15.4 | 17.1 | 10.9 | 17.0** |
| Sleep apnoea | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Arthritis | 1.6 | 1.4 | 2.2 | 2.1 | 2.8 | 1.5 | 3.1 |
| Osteoporosis | 6.0 | 2.9 | 12.1** | 12.0 | 12.7 | 4.9 | 18.5** |
| Dementia | 2.9 | 1.3 | 5.9** | 6.7 | 0.6** | 1.8 | 14.8** |
| Severe mental disorder | 1.7 | 1.5 | 2.0 | 2.1 | 1.1 | 1.5 | 4.3** |
| Immunodeficiencies | 0.4 | 0.3 | 0.5 | 0.5 | 0.6 | 0.4 | 0.6 |
| Neurological manifestations | 18.1 | 15.0 | 24.1** | 25.1 | 17.1 | 16.8 | 33.0** |
| Cancer | 10.3 | 6.3 | 18.0** | 17.8 | 18.8 | 8.8 | 27.5** |
| Chronic kidney failure | 2.4 | 0.7 | 5.7** | 5.6 | 6.6 | 1.8 | 9.6** |
| Dialysis | 0.5 | 0.1 | 1.3** | 1.3 | 1.1 | 0.4 | 1.5 |
| Hypertension | 30.1 | 18.3 | 52.5** | 48.6 | 78.5** | 27.0 | 65.1** |
Supplementary Table S2 holds information on diagnoses codes included in the individual comorbidity classifications. The table presents information on the full cohort (admitted and non-admitted SARS-CoV-2 positive patients) as well as subgroups admitted to a hospital and Intensive Care Unit (ICU) respectively. Furthermore, differential demographics between survivors and non-survivors (in-hospital mortality) is presented. Continuous variables are presented as medians with (interquartile range).
COPD chronic obstructive pulmonary disease.
**p < 0.001 when subgroups are compared (e.g. hospitalized vs. non-hospitalized, ICU vs. non-ICU, survivors vs. non-survivors).